Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia.
Saved in:
| Title: | Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia. |
|---|---|
| Authors: | Gil-Rojas Y; Department of Economic Studies, Neuroeconomix, Bogota, Colombia., Lasalvia P; Department of Economic Studies, Neuroeconomix, Bogota, Colombia., García Á; Cardiology Unit, San Ignacio University Hospital, Pontificia Universidad Javeriana, Bogotá, Colombia. |
| Source: | Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2022 Jun; Vol. 22 (4), pp. 655-663. Date of Electronic Publication: 2021 Nov 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34702123 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gil-Rojas+Y%22">Gil-Rojas Y</searchLink>; Department of Economic Studies, Neuroeconomix, Bogota, Colombia.<br /><searchLink fieldCode="AU" term="%22Lasalvia+P%22">Lasalvia P</searchLink>; Department of Economic Studies, Neuroeconomix, Bogota, Colombia.<br /><searchLink fieldCode="AU" term="%22García+Á%22">García Á</searchLink>; Cardiology Unit, San Ignacio University Hospital, Pontificia Universidad Javeriana, Bogotá, Colombia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101132257%22">Expert review of pharmacoeconomics & outcomes research</searchLink> [Expert Rev Pharmacoecon Outcomes Res] 2022 Jun; Vol. 22 (4), pp. 655-663. <i>Date of Electronic Publication: </i>2021 Nov 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101132257 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8379 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214737167%22">14737167 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Pharmacoecon Outcomes Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34702123 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/14737167.2022.1997595 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 655 Titles: – TitleFull: Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gil-Rojas Y – PersonEntity: Name: NameFull: Lasalvia P – PersonEntity: Name: NameFull: García Á IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2022 Jun Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1744-8379 Numbering: – Type: volume Value: 22 – Type: issue Value: 4 Titles: – TitleFull: Expert review of pharmacoeconomics & outcomes research Type: main |
| ResultId | 1 |
